Abstract:Poly(ADP-ribose)polymerase (PARP, EC 2.4.2.30), an abundant nuclear protein activated by DNA nicks, mediates cell death in vitro by nicotinamide adenine dinucleotide (NAD) depletion after exposure to nitric oxide. The authors examined whether genetic deletion of PARP (PARP null mice) or its pharmacologic inhibition by 3-aminobenzamide (3-AB) attenuates tissue injury after transient cerebral ischemia. Twenty-two hours after reperfusion following 2 hours of filamentous middle cerebral artery occlusion, ischemic injury was decreased in PARP−/− and PARP+/− mice compared with PARP+/+ litter mates, and also was attenuated in 129/SV wild-type mice after 3-AB treatment compared with controls. Infarct sparing was accompanied by functional recovery in PARP−/− and 3-AB–treated mice. Increased poly(ADP-ribose) immunostaining observed in ischemic cell nuclei 5 minutes after reperfusion was reduced by 3-AB treatment. Levels of NAD—the substrate of PARP—were reduced 2 hours after reperfusion and were 35% of contralateral levels at 24 hours. The decreases were attenuated in PARP−/− mice and in 3-AB–treated animals. Poly(ADP-ribose)polymerase cleavage by caspase-3 (CPP-32) has been proposed as an important step in apoptotic cell death. Markers of apoptosis, such as oligonucleosomal DNA damage, total DNA fragmentation, and the density of terminal deoxynucleotidyl transferase dUTP nick-end–labelled (TUNEL +) cells, however, did not differ in ischemic brain tissue of PARP−/− mice or in 3-AB–treated animals versus controls, although there were differences in the number of TUNEL-stained cells reflecting the decrease in infarct size. Thus, ischemic brain injury activates PARP and contributes to cell death most likely by NAD depletion and energy failure, although the authors have not excluded a role for PARP in apoptotic cell death at earlier or later stages in ischemic cell death. Inhibitors of PARP activation could provide a potential therapy in acute stroke.

Pyruvate improves recovery after PARP-1-associated energy failure induced by oxidative stress in neonatal rat cerebrocortical slices.

Antioxidant Effect of Ethyl Pyruvate in Respiring Neonatal Cerebrocortical Slices after H2O2 Stress

Role of Exogenous Pyruvate in Maintaining Adenosine Triphosphate Production under High-Glucose Conditions through PARP-Dependent Glycolysis and PARP-Independent Tricarboxylic Acid Cycle

Evogenous Ethyl Pyruvate Versus Pyruvate During Metabolic Recovery After Oxidative Stress In Neonatal Rat Cerebroconical Slices

PARP-1 inhibitor alleviates cerebral ischemia/reperfusion injury by reducing PARylation of HK-1 and LDH in mice

Nad Plus Treatment Can Attenuate The Oxidative Stress-Induced, Parp-Mediated Atp Depletion In Pc12 Cells

Mitochondrial Dysfunction Induced by Nuclear Poly(ADP-Ribose) Polymerase-1: a Treatable Cause of Cell Death in Stroke

Poly(ADP-ribose) Accumulation and Enhancement of Postischemic Brain Damage in 110-Kda Poly(ADP-ribose) Glycohydrolase Null Mice

Resveratrol Preconditioning Downregulates PARP1 Protein to Alleviate PARP1-Mediated Cell Death Following Cerebral Ischemia

Role of pyruvate in maintaining cell viability and energy production under high-glucose conditions

Ischemic Brain Injury is Mediated by the Activation of Poly(Adp-Ribose)Polymerase

The role of PARP activation in glutamate-induced necroptosis in HT-22 cells.

Effects of Augmented Delivery of Pyruvate on Myocardial High-Energy Phosphate Metabolism at High Workstate

Poly(ADP-ribose) Polymerase Gene Disruption Renders Mice Resistant to Cerebral Ischemia

ADP-ribose Transferase PARP16 Mediated-Unfolded Protein Response Contributes to Neuronal Cell Damage in Cerebral Ischemia/reperfusion

Neuroprotective Effects of Activated Protein C Involve the PARP/AIF Pathway against Oxygen-Glucose Deprivation in SH-SY5Y Cells

Delayed Treatment of NAD+ Can Restore Intracellular ATP Levels and Prevent PC12 Cell Death Induced by Oxidative Stress

NMDA but Not Non-NMDA Excitotoxicity is Mediated by Poly(ADP-Ribose) Polymerase

The advance of poly ADP-ribose polymerase-1 and poly ADP-ribose polymerase-1-dependent cell death in nervous system diseases

Poly (adp‐ribose) Polymerase Inhibition Protects Against Myocardial Ischaemia/reperfusion Injury Via Suppressing Mitophagy

Pyruvate improves cerebral metabolism during hemorrhagic shock